Royalty Pharma
(NASDAQ:RPRX)
$42.45
-0.06[-0.14%]
At close: Aug 5
$42.45
After Hours: 4:01PM EDT
Day High/Low42.32 - 43.58
52 Week High/Low36.15 - 44.75
Open / Close42.5 / 42.45
Float / Outstanding312.1M / 438.8M
Vol / Avg.3.6M / 2.1M
Mkt Cap18.6B
P/E41.21
50d Avg. Price41.87
Div / Yield0.76/1.79%
Payout Ratio69.9
EPS0.12
Total Float312.1M

Royalty Pharma (NASDAQ:RPRX), Quotes and News Summary

Royalty Pharma (NASDAQ: RPRX)

Day High/Low42.32 - 43.58
52 Week High/Low36.15 - 44.75
Open / Close42.5 / 42.45
Float / Outstanding312.1M / 438.8M
Vol / Avg.3.6M / 2.1M
Mkt Cap18.6B
P/E41.21
50d Avg. Price41.87
Div / Yield0.76/1.79%
Payout Ratio69.9
EPS0.12
Total Float312.1M
Sector: Health Care.Industry: Pharmaceuticals
Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS0.7800.700 -0.0800
REV542.180M535.955M-6.225M
Q1 2022Est.ActualSurprise
EPS0.7300.600 -0.1300
REV599.760M562.000M-37.760M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Royalty Pharma Questions & Answers

Q
How do I buy Royalty Pharma (RPRX) stock?
A

You can purchase shares of Royalty Pharma (NASDAQ: RPRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Royalty Pharma's (RPRX) competitors?
Q
What is the target price for Royalty Pharma (RPRX) stock?
A

The latest price target for Royalty Pharma (NASDAQ: RPRX) was reported by Tigress Financial on Thursday, July 14, 2022. The analyst firm set a price target for 57.00 expecting RPRX to rise to within 12 months (a possible 34.28% upside). 8 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Royalty Pharma (RPRX)?
A

The stock price for Royalty Pharma (NASDAQ: RPRX) is $42.45 last updated August 5, 2022, 8:00 PM UTC.

Q
Does Royalty Pharma (RPRX) pay a dividend?
A

The next Royalty Pharma (RPRX) dividend date is projected to be Thursday, August 18, 2022.

Q
When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?
A

Royalty Pharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Royalty Pharma (RPRX) going to split?
A

There is no upcoming split for Royalty Pharma.

Q
What sector and industry does Royalty Pharma (RPRX) operate in?
A

Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.